Determination of the lethal dose of dexamethasone for early passage in vitro human glioblastoma cell cultures

Robert J. Maciunas, Robert A. Mericle, Christopher L. Sneed, Deborah J. Hefner, Patricia A. Commers, William Kovacs

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

PREVIOUS INVESTIGATORS HAVE supported the idea that glucocorticoids may be oncolytic. In this study, the percentage of cell death in two human glioblastoma cell cultures was related to the concentration of dexamethasone that was administered. It was determined that for Cell line 1, the median lethal dose was approximately 500–800 μg/ml and the completely lethal dose was about 900–1000 μg/ml; the 3H-thymidine uptake to approximate the mitotic rate was 16,607 cpm, and the dexamethasone receptor activity was 228 fmol/mg protein. The median lethal dose and completely lethal dose for Cell line 2 was approximately 500–600 μg/ml and 700–1000 μg/ml, respectively; the 3H-thymidine uptake was 8402 cpm, and the dexamethasone receptor activity was 137 fmol/mg protein. These lethal concentrations of dexamethasone are probably higher than can be tolerated by systemic delivery. However, it remains to be seen whether the interstitial administration of dexamethasone could achieve local concentrations resulting in the oncolysis of malignant gliomas. The clinical significance of these findings will depend on the local tolerance of normal brain parenchyma to very high doses of dexamethasone. A review of some of the literature is included.

Original languageEnglish (US)
Pages (from-to)485-488
Number of pages4
JournalNeurosurgery
Volume33
Issue number3
StatePublished - Jan 1 1993

Fingerprint

Glioblastoma
Dexamethasone
Cell Culture Techniques
Thymidine
Cell Line
Glioma
Glucocorticoids
Proteins
Cell Death
In Vitro Techniques
Brain
dexamethasone receptor

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cite this

Maciunas, R. J., Mericle, R. A., Sneed, C. L., Hefner, D. J., Commers, P. A., & Kovacs, W. (1993). Determination of the lethal dose of dexamethasone for early passage in vitro human glioblastoma cell cultures. Neurosurgery, 33(3), 485-488.
Maciunas, Robert J. ; Mericle, Robert A. ; Sneed, Christopher L. ; Hefner, Deborah J. ; Commers, Patricia A. ; Kovacs, William. / Determination of the lethal dose of dexamethasone for early passage in vitro human glioblastoma cell cultures. In: Neurosurgery. 1993 ; Vol. 33, No. 3. pp. 485-488.
@article{90dec910a9274cef9ef1b0c47379c7aa,
title = "Determination of the lethal dose of dexamethasone for early passage in vitro human glioblastoma cell cultures",
abstract = "PREVIOUS INVESTIGATORS HAVE supported the idea that glucocorticoids may be oncolytic. In this study, the percentage of cell death in two human glioblastoma cell cultures was related to the concentration of dexamethasone that was administered. It was determined that for Cell line 1, the median lethal dose was approximately 500–800 μg/ml and the completely lethal dose was about 900–1000 μg/ml; the 3H-thymidine uptake to approximate the mitotic rate was 16,607 cpm, and the dexamethasone receptor activity was 228 fmol/mg protein. The median lethal dose and completely lethal dose for Cell line 2 was approximately 500–600 μg/ml and 700–1000 μg/ml, respectively; the 3H-thymidine uptake was 8402 cpm, and the dexamethasone receptor activity was 137 fmol/mg protein. These lethal concentrations of dexamethasone are probably higher than can be tolerated by systemic delivery. However, it remains to be seen whether the interstitial administration of dexamethasone could achieve local concentrations resulting in the oncolysis of malignant gliomas. The clinical significance of these findings will depend on the local tolerance of normal brain parenchyma to very high doses of dexamethasone. A review of some of the literature is included.",
author = "Maciunas, {Robert J.} and Mericle, {Robert A.} and Sneed, {Christopher L.} and Hefner, {Deborah J.} and Commers, {Patricia A.} and William Kovacs",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "33",
pages = "485--488",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Maciunas, RJ, Mericle, RA, Sneed, CL, Hefner, DJ, Commers, PA & Kovacs, W 1993, 'Determination of the lethal dose of dexamethasone for early passage in vitro human glioblastoma cell cultures', Neurosurgery, vol. 33, no. 3, pp. 485-488.

Determination of the lethal dose of dexamethasone for early passage in vitro human glioblastoma cell cultures. / Maciunas, Robert J.; Mericle, Robert A.; Sneed, Christopher L.; Hefner, Deborah J.; Commers, Patricia A.; Kovacs, William.

In: Neurosurgery, Vol. 33, No. 3, 01.01.1993, p. 485-488.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Determination of the lethal dose of dexamethasone for early passage in vitro human glioblastoma cell cultures

AU - Maciunas, Robert J.

AU - Mericle, Robert A.

AU - Sneed, Christopher L.

AU - Hefner, Deborah J.

AU - Commers, Patricia A.

AU - Kovacs, William

PY - 1993/1/1

Y1 - 1993/1/1

N2 - PREVIOUS INVESTIGATORS HAVE supported the idea that glucocorticoids may be oncolytic. In this study, the percentage of cell death in two human glioblastoma cell cultures was related to the concentration of dexamethasone that was administered. It was determined that for Cell line 1, the median lethal dose was approximately 500–800 μg/ml and the completely lethal dose was about 900–1000 μg/ml; the 3H-thymidine uptake to approximate the mitotic rate was 16,607 cpm, and the dexamethasone receptor activity was 228 fmol/mg protein. The median lethal dose and completely lethal dose for Cell line 2 was approximately 500–600 μg/ml and 700–1000 μg/ml, respectively; the 3H-thymidine uptake was 8402 cpm, and the dexamethasone receptor activity was 137 fmol/mg protein. These lethal concentrations of dexamethasone are probably higher than can be tolerated by systemic delivery. However, it remains to be seen whether the interstitial administration of dexamethasone could achieve local concentrations resulting in the oncolysis of malignant gliomas. The clinical significance of these findings will depend on the local tolerance of normal brain parenchyma to very high doses of dexamethasone. A review of some of the literature is included.

AB - PREVIOUS INVESTIGATORS HAVE supported the idea that glucocorticoids may be oncolytic. In this study, the percentage of cell death in two human glioblastoma cell cultures was related to the concentration of dexamethasone that was administered. It was determined that for Cell line 1, the median lethal dose was approximately 500–800 μg/ml and the completely lethal dose was about 900–1000 μg/ml; the 3H-thymidine uptake to approximate the mitotic rate was 16,607 cpm, and the dexamethasone receptor activity was 228 fmol/mg protein. The median lethal dose and completely lethal dose for Cell line 2 was approximately 500–600 μg/ml and 700–1000 μg/ml, respectively; the 3H-thymidine uptake was 8402 cpm, and the dexamethasone receptor activity was 137 fmol/mg protein. These lethal concentrations of dexamethasone are probably higher than can be tolerated by systemic delivery. However, it remains to be seen whether the interstitial administration of dexamethasone could achieve local concentrations resulting in the oncolysis of malignant gliomas. The clinical significance of these findings will depend on the local tolerance of normal brain parenchyma to very high doses of dexamethasone. A review of some of the literature is included.

UR - http://www.scopus.com/inward/record.url?scp=0027282341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027282341&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 485

EP - 488

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 3

ER -